If an oxidative dearomatization followed by a concomitant
carbon-carbon formation occurs, ꢀ-lactams with a rich
functionality could be readily provided and thus diverse
manipulation is possible. The success of such a procedure
may rely on the oxidative dearomatization of phenol deriva-
tives with proper oxidants. After an intensive survey of the
literature,4 we decided to use the readily available hyperva-
lent iodine reagents,5 namely, iodobenzene diacetate (IBD).
A program with the aim of synthesizing highly functional
spiro ꢀ-lactams, as shown in Scheme 1, was then initiated.
Having failed to effect the desired transformation, an
alternative way was thus sought. Because copper salts have
been widely employed in coupling reactions,6 we decided
to examine the combination of copper salts and IBD first. A
number of copper salts were tested, and the results are
summarized in Table 1. To our surprise, the addition of
Table 1. Attempts Towards the Synthesis of Spiro-ꢀ-lactamsa
Scheme 2. Initial Attempts Towards Oxidative Coupling
entry
copper salts
ligand (base)
solvent
yieldb
1
2
3
4
5
6
7
8
CuI
CuCl2
Cu(acac)2
Cu(OAc)2
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
CuSO4·5H2O
-
-
-
-
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
MeOH
CH3CN
MeOH
20%
25%
12%
24%
35%
<5%
<5%
<5%
51%
85%
57%c
30%
0%d
-
PPh3
Proline
TMEDA
Pyridine
DMAP
DMAP
DMAP
DMAP
9
The first amide (compound 1 in Scheme 2) was obtained
by the direct reaction of 4-(benzylamino)phenol with ethyl
3-chloro-3-oxopropanate in 92% yield. Although oxidation
of phenols with polyvalent iodine reagents to enone deriva-
tives has been well documented in the literature,8 no
oxidative reaction has ever been conducted using amide 1.
The initial oxidative coupling of amide 1 was then attempted
with IBD in methanol at room temperature. To our disap-
pointment, only cyclohexadienone 2 and 2a were detected
and no desired coupling reaction occurred. Using PIFA
(PhI(OCOCF3)2) as an oxidizing agent as well as using a
base (Et3N, DBU (1,8-diazabicyclo[5.4.0]undec-7-ene), NaH-
CO3 and K2CO3) as an additive to the reaction system did
not alter the reaction pathway, with compound 2 and
compound 2a being the isolated products. Varying the
solvents in the reaction system (dichloromethane, trifluoro-
ethanol, acetonitrile, ethyl acetate, DMF) was also fruitless.
10
11
12
13
a Reactions, except entry 11 and 13, were carried out at 0 °C with amide
1 (0.5 mmol) and IBD (0.6 mmol, 1.2 equiv) in a solvent (10 mL) for 1-2
h in the presence of a copper salt (0.5 mmol, 1.0 equiv). Entries 6-12
were carried out with a ligand (0.5-0.6 mmol). b Yields represent isolated
yields of 3. c Reaction was conducted at 0 °C with amide 1 (0.5 mmol),
IBD (0.6 mmol, 1.2 equiv), catalytic amount of CuSO4·5H2O (0.1 mmol)
and DMAP (0.12 mmol) for 2 h. d Reaction was conducted at 0 °C with
amide 1 (0.5 mmol), CuSO4·5H2O (1.2 mmol, 2.4 equiv) and DMAP (1.2
mmol) for 2 h in methanol (10 mL) in the absence of IBD.
copper salts resulted in the desired azetidinone 3. Charac-
teristic NMR peaks that were observed for compound 3 are
a singlet signal at 4.14 ppm in the 1H NMR spectrum and a
quaternary carbon resonance at 57.7 ppm in the 13C NMR
spectrum. The best result (Table 1, entry 10) was obtained
upon the addition of copper(II) sulfate pentahydrate and
4-dimethylaminopyridine (DMAP) in methanol. The desired
azetidinone (3) was obtained in 85% yield together with a
trace amount of byproduct 2a. In the absence of IBD,
however, copper(II) sulfate pentahydrate did not promote the
formation of the spiro-ꢀ-lactam (Table 1, entry 13).
To get further insights toward the generality of this
process, a number of phenol derived amides (1-1i) were
prepared and evaluated under optimized conditions. Good
yields were obtained, and the results are summarized in Table
2. After careful recrystallization, an X-ray crystal structure
for compound 3i was obtained and the spiro ꢀ-lactam
structure was confirmed. All azetidinone compounds listed
in Table 2 are bioactive against a number of tumor cell lines
with IC50 potencies ranging from 17 to 0.3 µM.7
(3) (a) Miyazawa, E.; Sakamoto, T.; Kikugawa, Y. Heterocycles 2003,
53, 149. (b) Wardrop, D. J.; Burge, M. S. J. Org. Chem. 2005, 70, 10271.
(c) Dohi, T.; Maruyama, A.; Minamitsuji, Y.; Takenaga, N.; Kita, Y. Chem.
Commun. 2007, 1224.
(4) For recent reviews on oxidative coupling, see: (a) Quideau, S.;
Pouysegu, L.; Deffieux, D. Synlett 2008, 467. (b) Ciufolini, M. A.; Braun,
N. A.; Canesi, S.; Ousmer, M.; Chang, J.; Chai, D. Synthesis 2007, 3759.
(c) Magdziak, D.; Meek, S. J.; Pettus, T. R. R. Chem. ReV. 2004, 104,
1383. (d) Rodr´ıgues, S.; Wipf, P. Synthesis 2004, 2767. (e) Van De Water,
R. W.; Pettus, T. R. R. Tetrahedron 2002, 58, 5367.
(5) For reviews on polyvalent iodine chemistry, see: (a) Zhdankin, V. V.;
Stang, P. J. Chem. ReV. 2008, 108, 5299. (b) Richardson, R. D.; Wirth, T.
Angew. Chem., Int. Ed. 2006, 45, 4402. (c) Wirth, T. Angew. Chem., Int.
Ed. 2005, 44, 3656. (d) Moriarty, R. M. J. Org. Chem. 2005, 70, 2893. (e)
Zhdankin, V. V.; Stang, P. J. Chem. ReV. 2002, 102, 2523, and references
cited therein.
(6) Evano, G.; Blanchard, N.; Toumi, M. Chem. ReV. 2008, 108, 3054.
(7) The bioassay was carried out with the MTT method. In vitro studies
demonstrated that the azetidinones listed in Table 2are active against A431,
HepG-2 and Skov-3 tumor cells.
(8) (a) Peng, H. M.; Wester, R. D. J. Org. Chem. 2008, 73, 2169. (b)
Eickhoff, H.; Jung, G.; Rieker, A. Tetrahedron 2001, 57, 353, references
cited therein.
The reaction pathway might consist of a radical coupling
reactions between the para-position of a phenol unit and the
Org. Lett., Vol. 11, No. 13, 2009
2821